Connor Haberl is a PhD Candidate in Biomedical Engineering at the University of Ottawa Heart Institute. His research focuses on improving mapping and treatment planning for cardiac radiotherapy through the integration of multimodal cardiac imaging and electrophysiology data. As part of his doctoral work, he is developing SHARP (Software for Heart Arrhythmia Radiotherapy Planning), a multimodal mapping and image-integration platform for cardiac radiotherapy designed to streamline target identification and treatment planning. Connor is also founder and CEO of CardiAxis Medical, which is translating SHARP from a research platform toward broader clinical use.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none